-
Jun 3, 2024 | 
law360.com | Kelly Hughes
ADVERTISEMENT Don't want ads? Subscribe or login now. Small Law By Kelly Hughes · Attorneys and other legal professionals share insights on mental health and well-being in this Law360 Pulse Expert Analysis series. If you'd like to write about these issues, please reach out to [email protected].... Want to continue reading?
-
Jan 11, 2024 | 
ipwatchdog.com | Eileen McDermott |Steve Brachmann |Kelly Hughes |Curtis Dodd
“A reviewing court is unable to adequately, reliably, or fairly give deferential review to a district court’s incomplete likelihood of confusion analysis that does not explain its factual findings and legal analysis of all relevant factors.” – Kroger petition Relish Labs LLC and the Kroger Company (who own the “Home Chef” brand and mark) petitioned the U.S. Supreme Court this week, asking the Justices to review a decision by the U.S. Court of Appeals for the Seventh Circuit that held Home...
-
Jan 11, 2024 | 
ipwatchdog.com | Kelly Hughes
The first week of 2024 was a light one for patent filings. The Patent Trial and Appeal Board (PTAB) had a slightly below average 21 new petitions—all petitions for inter partes review (IPR), while there were only 34 new filings in district court. The PTAB saw new IPRs filed against Advanced Coding (filed by Samsung), XR Communications (filed by Ericsson) and Semiconductor Design (filed by Cadence Design Systems). Four new IPRs challenging three Senko Advanced Components Inc.
-
Dec 7, 2023 | 
ipwatchdog.com | Eileen McDermott |Steve Brachmann |Tim Pohlmann |Kelly Hughes
“As IPWatchdog authors have reported previously, and today’s draft FRN concedes, the march-in provision has never been exercised in the history of the Bayh-Dole Act.
-
Dec 7, 2023 | 
ipwatchdog.com | Tim Pohlmann |Eileen McDermott |Kelly Hughes |David McCombs
Joe Casino is a partner and the Intellectual Property Chair at Wiggin and Dana and the Managing Trustee of Sun Patent Trust. Joe has been involved in licensing and patent enforcement for more than 25 years and is currently the Secretary for the Licensing Executives Society standard-setting program for developing an ANSI standard of best practices for licensing negotiations.
-
Dec 6, 2023 | 
ipwatchdog.com | Kelly Hughes |Eileen McDermott
It was an overall below-average week for patent filings at both the Patent Trial and Appeal Board (PTAB) and district courts. The PTAB had only 15 new PTAB petitions—all inter partes reviews (IPRs), while the district court had only 24 new complaints filed. There were two more Fintiv discretionary denials this week, with the Board denying institution of two IPRs filed by IBM against inventor-controlled DigitalDoor Inc.
-
Nov 24, 2023 | 
ipwatchdog.com | Eileen McDermott |Kelly Hughes |Steve Brachmann |Alec Pronk
“The court said that, on remand, the TTAB should ‘explain its decision regarding waiver of AMM’s Class 35 claims and, in particular, square its decision with the practices and procedures articulated in the T.B.M.P. and in its prior precedential decisions.’” The U.S. Court of Appeals for the Federal Circuit (CAFC) on Wednesday vacated and remanded a Trademark Trial and Appeal Board (TTAB) decision that had sustained an opposition to the mark GET ORDAINED, holding that the TTAB had failed to...
-
Oct 15, 2023 | 
ipwatchdog.com | Gene Quinn |Eileen McDermott |Kelly Hughes |Alec Pronk
“If you can’t sign on to these principles you can’t say you are pro-IP.
-
Oct 14, 2023 | 
ipwatchdog.com | Kelly Hughes |Alec Pronk |Eileen McDermott |Ty Davis
It was a relatively average week for patent filings in the district court with 59 new complaints. New filings included multiple filings associated with high-volume plaintiffs such as Jeffrey Gross, Leigh Rothschild, as well as a slew of filings from Pueblo Nuevo in a banking campaign. Meanwhile, XR Communications settled three inter partes reviews (IPRs) and filed two new cases against wireless carriers.
-
Aug 1, 2023 | 
onlinelibrary.wiley.com | Kelly Hughes |A. Moore |Marika L. Klosowski
Abstract Langerhans cell histiocytosis is a systemic histiocytic proliferative disease with cutaneous manifestations which is well described in human medical literature and has relatively recently been reclassified as a neoplastic disorder. The diagnosis of canine Langerhans cell histiocytosis has been proposed in the veterinary literature to refer to a histiocytic proliferative disease in the dog with clinical and histopathologic features that mirror the human disease.
